Clinical Trial Update: Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

This is an ongoing Phase 1/2 clinical trial evaluating a triple therapy of Botensilimab, Balstilimab, and Regorafenib in microsatellite-stable metastatic colore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Balstilimab (balstilimab)
• Botensilimab (botensilimab)
• Regorafenib (regorafenib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Advanced Colorectal Adenocarcinoma, Advanced Microsatellite Stable Colorectal Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING